Asia Beat: Blazing the biosimilar trail the Korean way
02:50 EDT 8 Aug 2012 | SCRIP
The first approval worldwide of a monoclonal antibody under formal biosimilar guidelines - infliximab in South Korea in late July - has whipped up industry interest in the country's biosimilars capabilities, at least if the hits on.....
Original Article: Asia Beat: Blazing the biosimilar trail the Korean way
More From BioPortfolio on "Asia Beat: Blazing the biosimilar trail the Korean way"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
